Fresh on the heels of Montreal Canadiens centre and JDRF National Spokesperson Max Domi’s announcement to join thousands of fellow participants at the Sun Life Walk to Cure Diabetes for JDRF in Montreal this Sunday, June 9, Max Domi joined 13 families in Montreal to discuss life with type 1 diabetes (T1D).
It has only been a few months since Rowena Chan started as Senior Vice-President of Sun Life Distributors, and she has already decided to step into the role of Honorary Chair for the Sun Life Walk to Cure Diabetes for JDRF.
Evelyn Riddell vividly remembers the year she began university as a happy and hopeful student embarking on the first step towards her future career.
However, adjusting to university life was difficult. Evelyn, who lives with type 1 diabetes (T1D), suffered from burnout, which affected many aspects of her life.
Earlier this month, JDRF celebrated a year of tremendous achievements and welcomed prominent scientists in the field to discuss their work at its You are JDRF Conference.
Young people living with a chronic illness like type 1 diabetes (T1D) often experience anxiety which – if not treated – can quickly spiral downwards into depression. However, the link between diabetes and depression remains poorly understood and under-researched. Depression is often viewed as a natural outcome of “diabetes distress” – the emotional burden of living with the disease.
Meet Noah Silvaggio, an ambitious 16-year-old JDRF youth ambassador who was voted one of Manitoba’s Top 40 Young People to Watch in 2018 in the category of community activism and social affairs.
Dr. Timothy Kieffer, a JDRF-funded investigator and professor in the Department of Cellular and Physiological Sciences and the Department of Surgery at the University of British Columbia, has been awarded a new two-year grant to continue his research involving insulin-producing cells as a potential cure for type 1 diabetes (T1D). Read on to learn more about his current research study.
Clinical islet transplantation is viewed as a viable treatment that has the potential to eliminate a life-long dependence on insulin in individuals with type 1 diabetes (T1D). Dr. Shapiro breaks down the three areas his research study will focus on.
Dr. Anne Maria Pesenacker, a JDRF-funded investigator at the University of British Columbia and now at UCL’s Institute of Immunity and Transplantation, is examining how regulatory T cells (Tregs) function in health and how best to monitor their fitness.
The development of encapsulation technologies to treat insulin-dependent diabetes has been at the forefront of type 1 diabetes (T1D) research in North America for many years. This is because new methods of cell delivery may offer a functional cure for people with T1D at high risk for life-threating complications.
It goes without saying that social media has become the way we share snippets of our lives. Not only has it revolutionized how we get a glimpse into those of our friends and family, but it has radically changed how we learn about the world around us, how we engage with government and how we unite to make our planet a better place to live.
Guest blog post by Nguyet (Na) Nguyen and Sarah Strong
The Provincial Day of Action is a yearly event where medical students identify a gap in the healthcare system and approach our provincial government with an “ask” to help fix that gap. This year, as students in the Faculty of Medicine at Memorial University of Newfoundland, we asked the provincial government to remove the age restrictions in place for financial coverage of insulin pumps for people living with type 1 diabetes (T1D) in Newfoundland and Labrador.
